HK inno.N's new drug for gastroesophageal reflux disease, K-Cab, is expected to enter the Australian and New Zealand markets, leading to expectations for good performance.
Nature Republic has surpassed ¥4.7 billion (approximately KRW 43.6 billion) in cumulative supply sales in Japan within just three years, driven by its offline-focused market strategy.
Lee Jang-han, Chairman of Chong Kun Dang, stated, "This year must be dedicated to maximizing management efficiency through the establishment and execution of practical strategies." in his New Year’s address on January 2.
Samsung Electronics reported on Wednesday that it posted KRW 7.91 trillion in sales and KRW 9.18 trillion in operating profit in the third quarter of this year.
Hanwha Solutions has continued to post operating losses for three consecutive quarters, but reduced its deficit in the third quarter by improving profitability in its engineering, procurement, and construction(EPC) business.